Advert - Chiesi

For promoting Fostair for an unlicensed indication and breaching a previous undertaking given in that regard, Chiesi was ruled in breach of the following clauses of the Code:

Clause 1.8 - Failing to comply with all applicable codes, laws, and regulations.

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry.

Clause 3.2 - Promoting a medicine for an unlicensed indication.

Clause 9.1 - Failing to maintain high standards.

Clause 25 - Failing to comply with an undertaking.

The Code of Practice Panel was concerned about the difficulty in obtaining the relevant information from Chiesi and the inconsistency of that information. The Panel reported Chiesi to the Code of Practice Appeal Board which decided to publicly reprimand Chiesi for its failure to provide complete and accurate information at the outset. It also required an audit of Chiesi’s procedures.

Advert - February 2013